Article

NextGen Therapies Industry Working Group

A Deloitte-led initiative that brings together advanced therapy leaders with a passion to learn, share best practices, and move the industry forward, together

Welcome to the NextGen Therapies Industry Working Group (IWG)

Where advanced therapy leaders come together

Deloitte's NextGen Therapies Industry Working Group, established in 2019, serves as a forum for exchanging perspectives and driving actionable discussion on critical topics that impact patient access to transformational therapies. The IWG hosts executive meetings to discuss relevant industry topics, address pain points, and identify opportunities to raise the tide for all the boats. The IWG’s mission is to foster collaboration among advanced therapy leaders, enabling them to share cutting-edge practices, harmonize industry-wide standards, and co-create transformative solutions that ultimately enhance the lives of patients, providers, and other relevant stakeholders.

The IWG is a discussion-focused, action-oriented forum where members are passionate about collaborating to improve access for patients to these transformative therapies.

Watch our video to learn more.

Let’s make this work.

To view this video, change your analytics/performance cookie settings.

Dive into our latest CGT-related thinking and perspectives

Close
2024 advanced therapy industry report
Dive into the findings from our 2024 state of the advanced therapy industry report, highlighting important trends and insights from 376 industry stakeholders across the cell and gene therapy market.
false
Learn more
Close
CGT Market Index
The Cell and Gene Therapy (“CGT”) Market IndexTM helps senior executives make strategic decisions by exploring value maximization opportunities during key life events for CGT companies.
false
Learn more
Close
NextGen cell and gene therapy
How can life sciences organizations address current industry challenges and continue to advance CGT? Together, we can advance the business of cell and gene therapies.
false
Learn more
Close
March 2023 quarterly meeting: Summary and panel discussion
Read the summary recap of our March 2023 event, including detailed takeaways from the panel session “From BMT to CGT: Evolution of a dynamic health care model.”
false
Learn more
Close
ConvergeHEALTH™ CGT Vantage
Discover how our software-as-a-service solution can help optimize and manage the end-to-end patient treatment journey for cell and gene therapies.
false
Learn more
${column-img-description}

Join us at our next event

Our next meeting will be November 5 - 6, 2025 in Boston, MA. Contact us to learn more.

Register now

NextGen Therapies (NGT) Academy

NGT Academy provides industry leading practices, education, and thought leadership on specific topics of interest at each stage of an advanced therapy company’s lifecycle. We deliver low-cost, high-value services primarily through customized virtual courses and immersion labs ranging in duration from 1 hour to full-day with the ability to facilitate in-person, virtual, or hybrid environments.

 

Learn more

Collaborate, innovate, lead: Contact us to learn more about the IWG

Have any questions about the NextGen Therapies Industry Working Group, our workstreams, or our upcoming events? If you’d like to talk or learn more, let’s set up a conversation.

 
 
 
 
 
 
 
  Yes         No

 

Hussain Mooraj
Principal | Deloitte Consulting LLP
hmooraj@deloitte.com
+1 508 561 9266

Amit Agarwal
Managing Director | Life Sciences
amitagarwal2@deloitte.com
+1 415 783 6691

Jennifer Rabin
Specialist Leader
jerabin@deloitte.com
+1 703 251 3548

Jessica Faust
Client Relationship Executive
jfaust@deloitte.com
+1 774 225 8013

Did you find this useful?